Gene analysis helps identify basis of rare infant heart disorder
A study reported in the current issue of the journal Pediatric and Developmental Pathology compares cardiac tissue from 12 patients with HC and 12 age-matched controls. Researchers found differences in gene expression that could indicate a predisposition for HC.
HC typically occurs in the first 2 years of life. It affects females three times more often than males, leading to the theory that it is an X chromosome-linked disorder with prenatal death is occurring in males. Eighty percent of the cases occur in whites; 15 percent in blacks; and 3 percent in Latin Americans. It is very rare in those of Asian heritage.
A worldwide registry of HC was started in 1999, attempting to identify the gene responsible for this fatal disorder. These data have shown a family tendency for the disease.
The gene analysis undertaken in the current study found decreased protein expression, or downregulation, in two sets of genes aligned sequentially along the genome. This offers several genes as candidates for the mutation, possibly predisposing individuals to HC.
The downregulation of a particular gene could result in reduced survival of cardiac myocytes, leading to cardiac failure during a baby’s development. These candidate genes now will offer a starting point for further research for inherited patterns of mutation. Utilizing the HC registry, researchers will seek to confirm the findings of this study and to collect and analyze blood from parents and siblings of HC patients in an effort to further expose the inheritance pattern.
Original publication
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.